Rapid efficacy of anifrolumab in refractory cutaneous dermatomyositis.

Grolleau C, Mahévas T, Daniel P, Schleinitz N, Seneschal J, Doutre MS, Richez C, Rigolet A, Champtiaux N, Combemale L, Langlois V, Jacobzone-Leveque C, Vautier M, Toussaint C, Delpuech A, Paul C, Dupin N, Bugaut H, Chasset F, Lesort C, Paule R, Gallay L, Charvet E, Jachiet M, Cassius C, Bouaziz JD, Benveniste O, Allenbach Y, EMSED study group

Open source

DOI: 10.1111/jdv.70580
Published: 2026 Jul 14
Container: Journal of the European Academy of Dermatology and Venereology : JEADV
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/jdv.70580,
  title = {Rapid efficacy of anifrolumab in refractory cutaneous dermatomyositis.},
  author = {Grolleau C and Mahévas T and Daniel P and Schleinitz N and Seneschal J and Doutre MS and Richez C and Rigolet A and Champtiaux N and Combemale L and Langlois V and Jacobzone-Leveque C and Vautier M and Toussaint C and Delpuech A and Paul C and Dupin N and Bugaut H and Chasset F and Lesort C and Paule R and Gallay L and Charvet E and Jachiet M and Cassius C and Bouaziz JD and Benveniste O and Allenbach Y and EMSED study group},
  year = {2026},
  journal = {Journal of the European Academy of Dermatology and Venereology : JEADV},
  doi = {10.1111/jdv.70580},
  url = {https://doi.org/10.1111/jdv.70580}
}

RIS

TY  - JOUR
TI  - Rapid efficacy of anifrolumab in refractory cutaneous dermatomyositis.
AU  - Grolleau C
AU  - Mahévas T
AU  - Daniel P
AU  - Schleinitz N
AU  - Seneschal J
AU  - Doutre MS
AU  - Richez C
AU  - Rigolet A
AU  - Champtiaux N
AU  - Combemale L
AU  - Langlois V
AU  - Jacobzone-Leveque C
AU  - Vautier M
AU  - Toussaint C
AU  - Delpuech A
AU  - Paul C
AU  - Dupin N
AU  - Bugaut H
AU  - Chasset F
AU  - Lesort C
AU  - Paule R
AU  - Gallay L
AU  - Charvet E
AU  - Jachiet M
AU  - Cassius C
AU  - Bouaziz JD
AU  - Benveniste O
AU  - Allenbach Y
AU  - EMSED study group
PY  - 2026
JO  - Journal of the European Academy of Dermatology and Venereology : JEADV
DO  - 10.1111/jdv.70580
UR  - https://doi.org/10.1111/jdv.70580
ER  -

APA

C, G., T, M., P, D., N, S., J, S., MS, D., C, R., A, R., N, C., L, C., V, L., C, J., M, V., C, T., A, D., C, P., N, D., H, B., F, C., C, L., R, P., L, G., E, C., M, J., C, C., JD, B., O, B., Y, A., & group, E. S. (2026). Rapid efficacy of anifrolumab in refractory cutaneous dermatomyositis.. Journal of the European Academy of Dermatology and Venereology : JEADV. https://doi.org/10.1111/jdv.70580

Source records

pubmed · retrieved 2026-09-26T19:30:33.103Z